News & Insights
News & Insights
The latest on investor advocacy.
Newest first
November 2024
Nov 14, 2024
Press Releases
7 min read
Buxton Helmsley Calls for Senate Hearing on Well-Documented Evident Clinical Data Fraud at Assertio
7 min read
Nov 10, 2024
Press Releases
8 min read
Buxton Helmsley Releases Evidence of Product-Related Fraud at Assertio
8 min read
Nov 7, 2024
Press Releases
8 min read
Buxton Helmsley Issues Letter to Assertio Stockholders Disclosing Inversion to Short Position Following Board Refusal to Address Product-Related Fraud
8 min read
May 2024
May 16, 2024
Press Releases
13 min read
Buxton Helmsley Releases Letter From Certified Fraud Examiner Attesting To Disclosure Failures And Deficiencies By Assertio Holdings Board of Directors
13 min read
May 12, 2024
Press Releases
13 min read
Buxton Helmsley Urges Assertio Stockholders to Vote “Against” Directors After Disclosure Failures, Inappropriate Boardroom Activity, Strategic Blunders
13 min read
The Buxton Helmsley Brief.
Research, campaign updates, and market commentary, delivered as they publish.